Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke

Post-stroke cognitive impairment (PSCI) is a common complication following a stroke that significantly affects patients’ quality of life and rehabilitation outcomes. It also imposes a heavy economic burden. There is an urgent need to better understand the pathophysiology and pathogenesis of PSCI, as...

Full description

Saved in:
Bibliographic Details
Main Authors: Huaqiang Li, Xiaohua Ke, Bianying Feng, Huan Tian, Zhenzhen Cai, Anren Zhang, Qiuhong Man
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1500650/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591920777396224
author Huaqiang Li
Huaqiang Li
Xiaohua Ke
Bianying Feng
Huan Tian
Huan Tian
Zhenzhen Cai
Anren Zhang
Qiuhong Man
author_facet Huaqiang Li
Huaqiang Li
Xiaohua Ke
Bianying Feng
Huan Tian
Huan Tian
Zhenzhen Cai
Anren Zhang
Qiuhong Man
author_sort Huaqiang Li
collection DOAJ
description Post-stroke cognitive impairment (PSCI) is a common complication following a stroke that significantly affects patients’ quality of life and rehabilitation outcomes. It also imposes a heavy economic burden. There is an urgent need to better understand the pathophysiology and pathogenesis of PSCI, as well as to identify markers that can predict PSCI early in the clinical stage, facilitating early prevention, monitoring, and treatment. Although the mechanisms underlying PSCI are complex and multifaceted, involving factors such as atherosclerosis and neuroinflammation, metabolic disorders also play a critical role. This article primarily reviews the relationship between metabolic disorders of the three major nutrients—sugar, fat, and protein—and the development of cognitive dysfunction following ischemic stroke (IS). It aims to elucidate how these metabolic disturbances contribute to cognitive dysfunction post-stroke and to explore potential metabolic biomarkers for PSCI. We believe that this review will offer new insights into the early identification, treatment, and prognostic assessment of PSCI.
format Article
id doaj-art-8e01fd452f1542bf9803605b2c70cf5e
institution Kabale University
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-8e01fd452f1542bf9803605b2c70cf5e2025-01-22T05:19:24ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011610.3389/fendo.2025.15006501500650Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic strokeHuaqiang Li0Huaqiang Li1Xiaohua Ke2Bianying Feng3Huan Tian4Huan Tian5Zhenzhen Cai6Anren Zhang7Qiuhong Man8Department of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Clinical Laboratory, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaSchool of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Clinical Laboratory, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Clinical Laboratory, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaPost-stroke cognitive impairment (PSCI) is a common complication following a stroke that significantly affects patients’ quality of life and rehabilitation outcomes. It also imposes a heavy economic burden. There is an urgent need to better understand the pathophysiology and pathogenesis of PSCI, as well as to identify markers that can predict PSCI early in the clinical stage, facilitating early prevention, monitoring, and treatment. Although the mechanisms underlying PSCI are complex and multifaceted, involving factors such as atherosclerosis and neuroinflammation, metabolic disorders also play a critical role. This article primarily reviews the relationship between metabolic disorders of the three major nutrients—sugar, fat, and protein—and the development of cognitive dysfunction following ischemic stroke (IS). It aims to elucidate how these metabolic disturbances contribute to cognitive dysfunction post-stroke and to explore potential metabolic biomarkers for PSCI. We believe that this review will offer new insights into the early identification, treatment, and prognostic assessment of PSCI.https://www.frontiersin.org/articles/10.3389/fendo.2025.1500650/fullischemic strokecognitive dysfunctionmetabolic disordersbiomarkersreview
spellingShingle Huaqiang Li
Huaqiang Li
Xiaohua Ke
Bianying Feng
Huan Tian
Huan Tian
Zhenzhen Cai
Anren Zhang
Qiuhong Man
Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
Frontiers in Endocrinology
ischemic stroke
cognitive dysfunction
metabolic disorders
biomarkers
review
title Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
title_full Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
title_fullStr Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
title_full_unstemmed Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
title_short Research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
title_sort research progress on the mechanism and markers of metabolic disorders in the occurrence and development of cognitive dysfunction after ischemic stroke
topic ischemic stroke
cognitive dysfunction
metabolic disorders
biomarkers
review
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1500650/full
work_keys_str_mv AT huaqiangli researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT huaqiangli researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT xiaohuake researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT bianyingfeng researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT huantian researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT huantian researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT zhenzhencai researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT anrenzhang researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke
AT qiuhongman researchprogressonthemechanismandmarkersofmetabolicdisordersintheoccurrenceanddevelopmentofcognitivedysfunctionafterischemicstroke